Ann: CEO 100 Day Update, page-5

First 5 Last

Share
Profile

Follow
guildford

239 Posts.

0

09/03/18

18:12

Post #: 31652831
Share

Originally posted by Blackpanther ↑

I was lucky enough to sneak out of work to hear the conference call. Mario sounded professional and like he can really bring this product to market with the experience he has in other product launches in big pharma companies he has worked for

He also said that if he launched a product like this with no competition and achieved 5% market share, the product would have been seen as a failure at a big company...

Well for RSH a market penetration of only %5 would be revenue to RSH if $260 000 000 (on slide 33 of yesterday’s announcement) and this is only for North America, Germany, UK and Australia...

Gee at such a cheap valuation shouldn’t this stock re rate a hell of a lot!??

What about the Asian market - respiratory diseases are rife there and so is air pollution..?

I liked the questions at the end of the conference call about commercialisation and partnerships etc and I believe Mario had a balanced and realistic approach.

Good luck to him and he team and I’m very sure that mums like me will buy this when it’s available. I also think that when potential purchasers of the product, be they asthma sufferers or their carers, Get to see one working I believe they will be impressed and appreciate the piece of mind this provides them.

As Mario said on the call, the other chronic diseases like heart conditions and diabetes have monitoring devices but Asthmatics don’t!!

This is truely disruptive and it’s all unfolding so quickly. I actually very excited to have found this stock!

Thx fellow RSH posters and good luck to us all!

Expand

Could someone remind me what John Ribot brings to the board and at what cost. Might have been ok at Lang Park back in the day but this company??? seems very out of place

RSH Price at posting: 8.0¢ Sentiment: Hold Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

DBO

Diablo expands critical minerals footprint at Star Range

KAO

Kaoko Metals begins Chalkos drilling

KLV

Klevo Rewards advances stablecoin strategy with credit licence acquisition

AS2

Nejo approvals the trigger for Askari Metals as maiden Ethiopian campaign looms

Expert Exchange: SpaceX plummets back down to earth after explosive IPO debut

Expert Exchange: The Kouk on Michelle Bullock's legacy as RBA Governor

FRX

Flexiroam partners with Etihad Airways to accelerate enterprise growth

AFP

AFT Pharmaceutical's multi-billion R&D opportunity

PL9

Prairie Lithium advances towards first production as commercial DLE unit arrives

14D

1414 Degrees: Inside the SiNTL battery pivot to drones, defence

First 5 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Ann: CEO 100 Day Update, page-5

Top Stories

Diablo expands critical minerals footprint at Star Range

Kaoko Metals begins Chalkos drilling

Klevo Rewards advances stablecoin strategy with credit licence acquisition

Nejo approvals the trigger for Askari Metals as maiden Ethiopian campaign looms

Expert Exchange: SpaceX plummets back down to earth after explosive IPO debut

Expert Exchange: The Kouk on Michelle Bullock's legacy as RBA Governor

Flexiroam partners with Etihad Airways to accelerate enterprise growth

AFT Pharmaceutical's multi-billion R&D opportunity

Prairie Lithium advances towards first production as commercial DLE unit arrives

1414 Degrees: Inside the SiNTL battery pivot to drones, defence